Strong Market Presence União Química is one of the largest and most established pharmaceutical companies in Brazil with over 87 years of operation, a solid local capital base, and a diversified portfolio developed through acquisitions and modern manufacturing facilities. This positions them as a key player with a broad footprint in the regional market, opening opportunities for partnerships and supply chain collaborations.

Global Biotech Expansion The company operates nine manufacturing plants in Brazil and one biotech facility in the United States, indicating an active focus on biotechnological innovations and international growth. This expansion presents avenues for advanced technology partnerships and co-development projects targeting high-growth biotech segments.

Strong Financial Momentum Recent financing of $67.2 million from the International Finance Corporation highlights their capacity for growth investment, coupled with annual revenues between $50 million and $100 million. This financial strength supports potential collaboration on large-scale R&D projects, joint ventures, and capacity expansion initiatives.

Sustainability Commitment The launch of the Raízes da União program, aiming to plant one million native trees over five years, demonstrates their dedication to social and environmental responsibility. Partnering on sustainability projects and eco-friendly initiatives could resonate well with their values and enhance corporate social responsibility collaborations.

Community and Employee Engagement With a workforce exceeding 7,500 employees and proactive community engagement programs, União Química shows strong internal and external stakeholder focus. Opportunities exist for offering employee wellness solutions, corporate wellness programs, or community health initiatives that align with their values and expand their social impact footprint.